Macquarie Group’s Tvardi Therapeutics, Inc. Common Stock TVRD Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q3 | – | Sell |
-66
| Closed | -$614 | – | 1948 |
|
2024
Q2 | $614 | Buy |
+66
| New | +$614 | ﹤0.01% | 1868 |
|
2022
Q4 | – | Sell |
-27
| Closed | -$14K | – | 2412 |
|
2022
Q3 | $14K | Sell |
27
-14
| -34% | -$7.26K | ﹤0.01% | 2295 |
|
2022
Q2 | $14K | Hold |
41
| – | – | ﹤0.01% | 2396 |
|
2022
Q1 | $18 | Hold |
41
| – | – | ﹤0.01% | 2414 |
|
2021
Q4 | $18K | Hold |
41
| – | – | ﹤0.01% | 2423 |
|
2021
Q3 | $23K | Buy |
41
+27
| +193% | +$15.1K | ﹤0.01% | 2427 |
|
2021
Q2 | $7K | Hold |
14
| – | – | ﹤0.01% | 2508 |
|
2021
Q1 | $11K | Sell |
14
-7
| -33% | -$5.5K | ﹤0.01% | 2384 |
|
2020
Q4 | $11K | Hold |
21
| – | – | ﹤0.01% | 2301 |
|
2020
Q3 | $10K | Hold |
21
| – | – | ﹤0.01% | 2284 |
|
2020
Q2 | $13K | Buy |
+21
| New | +$13K | ﹤0.01% | 2254 |
|